Chapter 11 of Phlebotomy Essentials (7th and 8th editions) focuses on Special Collections and Point-of-Care Testing (POCT). This chapter covers procedures that require extra steps, such as blood cultures, therapeutic drug monitoring, and testing performed at the patient’s bedside.

newtopiccyclegrowin
5 pages
Pathology
newtopiccyclegrowin
5 pages
Pathology
231
/ 5
Phlebotomy Essentials (Chapter 11 Key Terms)
Study online at https://quizlet.com/_zowm1
ACT Activated clotting time
Aerobic With air
Anaerobic Without air
ARD Antimicrobial removal device
Autologous
Blood that is donated for one's own
use
BAC Blood alcohol concentration
Bacteremia Bacteria in the blood
BNP B-Type natriuretic peptide
BT Bleeding time test
Chain of custody
Special strict protocol for forensic
specimens that require detailed docu-
mentation tracking the specimen from
the time it is collected until the results
are reported.
Compatibility
1 / 5
Phlebotomy Essentials (Chapter 11 Key Terms)
Study online at https://quizlet.com/_zowm1
Ability to be mixed together with fa-
vorable results, as in blood transfu-
sions.
CRP C-reactive protein
EQC
Instrument that detects problems with
the specimen
ETOH Ethanol or blood alcohol
FAN Fastidious antimicrobial neutralization
FUO Fever of unknown origin
GTT Glucose Tolerance Test
hCG Human chorionic gonadotropin
Hyperglycemia
High blood sugar condition, as in dia-
betes mellitus
Hypoglycemia Low blood sugar condition
Hyperkalemia High blood potassium concentration
Hypokalemia Low blood potassium concentration
Hypernatremia High blood sodium
2 / 5
Phlebotomy Essentials (Chapter 11 Key Terms)
Study online at https://quizlet.com/_zowm1
Hyponatremia Low blood sodium
Hypoxemia Low level of oxygen in the blood
iCa2 Ionized calcium
INR International Normalized Ratio
K+ Potassium
Lactate
A form of lactic acid that is used as a
marker of the severity of metabolic aci-
dosis and a patient's stress response
Lookback
Program that requires all components
of a unit of blood to be traceable back
to the donor and that also requires no-
tification to all blood recipients when
a donor for a blood product they have
received had turned positive for a
transmissible disease
Lysis Rupturing, as in the bursting of RBCs
NIDA National Institute on Drug Abuse
3 / 5
/ 5
End of Document
231

You May Also Like

Related